SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000944209-98-000311
Filing Date
1998-02-12
Accepted
1998-02-12 00:00:00
Documents
4
Group Members
MARK E. STROMESSCO, INCSTROME SUSSKIND INVESTMENT MANAGEMENT LP
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 16892
2 POWER OF ATTORNEY FORMS EX-1 1476
3 JOINT FILING AGREEMENT EX-2 1326
4 IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY EX-3 879
  Complete submission text file 0000944209-98-000311.txt   22890
Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44877 | Film No.: 98535690
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 WILSHIRE BLVD 15TH FLOOR SANTA MONICA CA 90401
Business Address 100 WILSHIRE BLVD 15TH FLOOR SANTA MONICA CA 90401
STROME SUSSKIND INVESTMENT MANAGEMENT LP (Filed by) CIK: 0000936711 (see all company filings)

IRS No.: 954450882 | State of Incorp.: DE | Fiscal Year End: 1231